Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Methode Electronics (NY: MEI )

9.720 +0.690 (+7.64%)
Official Closing Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Methode Electronics

< Previous 1 2 3 4 5 6 7 Next >
The Law Offices of Frank R. Cruz Announces Investigation of Methode Electronics, Inc. (MEI) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Methode Electronics, Inc. Investors to Inquire About Securities Class Action Investigation - MEI
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
METHODE ALERT: Bragar Eagel & Squire, P.C. is Investigating Methode Electronics Inc. on Behalf of Methode Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Earnings Outlook For Methode Electronics
Via Benzinga
A Preview Of Methode Electronics's Earnings
Via Benzinga
Why Methode Electronics Shares Are Falling Today
Methode Electronics, Inc. (NYSE: MEI) reported a  
Via Benzinga
Recap: Methode Electronics Q4 Earnings
Via Benzinga
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Methode Electronics, Inc. Investors to Inquire About Securities Class Action Investigation – MEI
From The Rosen Law Firm, P.A.
Via Business Wire
Methode Electronics Shares Slump As Looming Softness In EV market & UAW Strikes Weigh On Q2 Earnings, Lowers Guidance
Methode Electronics, Inc. (NYSE: MEI) reported a second-quarter FY24 net sales decline of 8.8% year-on-year to $288 million,  
Via Benzinga
MEI Stock Earnings: Methode Electronics Misses EPS, Misses Revenue for Q2 2024
MEI stock results show that Methode Electronics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For December 7, 2023
Companies Reporting Before The Bell • IES Hldgs (NASDAQ:IESC) is expected to report earnings for its fourth quarter. 
Via Benzinga
Methode Electronics's Earnings Outlook
Via Benzinga
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings. 
Via Benzinga
Insiders Buying Blackstone, STAAR Surgical And 2 Other Stocks
Although U.S. stocks closed lower on Friday, there were a few notable insider trades. 
Via Benzinga
The One-Minute Market Report - Sunday, Sept. 10
In this weekly market outlook, we take a look at the various asset classes, industries, equity categories, and exchange-traded funds that moved the market higher and the market segments that defied the... 
Via Talk Markets
Why Methode Electronics Stock Fell Hard Today
Methode Electronics missed earnings estimates and lowered its full-year outlook. Here's what happened. 
Via The Motley Fool
12 Information Technology Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for... 
Via Benzinga
Methode Electronics Shares Fall On Mixed Q1 Earnings Results & Dismal Outlook
Methode Electronics, Inc. (NYSE: MEI) reported a first-quarter FY24 net sales growth of 2.6% year-on-year to $289.7 million,  
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Scheduled For September 7, 2023
Companies Reporting Before The Bell • Tsakos Energy Navigation (NYSE:TNP) is likely to report quarterly earnings at $1.60 per share on revenue of $174.10 million. 
Via Benzinga
Commitment to Shareholders amid Decreased Earnings: Methode Electronics Ensures Steady Distribution
By the end of today, July 28, 2023, Methode Electronics (NYSE:MEI) is set to deliver a dividend payout of $0.14 per share, equating to an annualized dividend yield of 1.51%. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 54 companies hit new 52-week lows. 
Via Benzinga
Top 5 Tech Stocks You'll Regret Missing This Quarter
The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Top 5 Tech Stocks You'll Regret Missing In Q2
The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
Via Benzinga
Nasdaq Gains Over 50 Points; First Wave BioPharma Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.23% to 34,144.24 while the NASDAQ rose 0.42% to 13,518.40. The S&P 500,... 
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dow, Nasdaq Up Triple Digits; CPI Data Still In Focus
Stocks are firmly higher this afternoon. 
Via Talk Markets
Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 143% to $2.77 after the company achieved its enrollment target for its adrulipase Phase 2 SPAN trial for exocrine pancreatic... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.